By a News Reporter-Staff News Editor at Biotech Week -- Data detailed on Myeloma have been presented. According to news reporting originating from Tampa, Florida, by NewsRx correspondents, research stated, “Although recent advances in novel treatment approaches and therapeutics have shifted the treatment landscape of multiple myeloma, it remains an incurable plasma cell malignancy. Growing knowledge of the genome and expressed genomic information characterizing the biologic behavior of multiple myeloma continues to accumulate.”
Our news editors obtained a quote from the research from H. Lee Moffitt Cancer Center and Research Institute, “However, translation and incorporation of vast molecular understanding of complex tumor biology to deliver personalized and precision treatment to cure multiple myeloma have not been successful to date. Our review focuses on current evidence and understanding of myeloma biology with characterization in the context of genomic and molecular alterations.”
According to the news editors, the research concluded: “We also discuss future clinical application of the genomic and molecular knowledge, and more translational research is needed to benefit our myeloma patients.”
For more information on this research see: Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review. International Journal of Genomics , 2017;2017():6934183.
The news editors report that additional information may be obtained by contacting T. Nishihori, Dept. of Blood and Marrow Transplantation, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1155/2017/6934183. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-01-03), Researchers from H. Lee Moffitt Cancer Center and Research Institute Report on Findings in Myeloma (Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise ...), Biotech Week, 236, ISSN: 1537-4699, BUTTER® ID: 014911078
From the newsletter Biotech Week.
https://www.newsrx.com/Butter/#!Search:a=14911078
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.